Metaplanet
3350
Nippon Telegraph & Telephone
9432
Remixpoint
3825
4
Mitsubishi
8058
5
Toyota Motor
7203
JP Stock MarketDetailed Quotes
2160 GNI Group
- 3375
- -70-2.03%
20min DelayMarket Closed Feb 28 15:30 JST
169.35BMarket Cap179.24P/E (Static)
3525High3350Low839.50KVolume3375Open3445Pre Close2.87BTurnover397052wk High1.78%Turnover Ratio50.18MShares153752wk Low18.83EPS TTM159.66BFloat Cap4070Historical High179.24P/E (Static)47.31MShs Float13Historical Low18.83EPS LYR5.08%Amplitude--Dividend TTM4.65P/B100Lot Size--Div YieldTTM
About GNI Group Company
GNI Group Ltd is a clinical stage drug development company. It works on the treatment of diseases that are more common in Asia, especially Japan and China. It is engaged in the discovery, development, manufacture, and sale of drugs for the treatment of cancer and inflammatory diseases.
Company Profile
Symbol2160
Company NameGNI Group
Founded2001-11-20
MarketTSE Growth
Employees839
Fiscal Year Ends12-31
AddressShinjuku Park Tower 3-7-1 Nishi-Shinjuku
Zip Code103-0023
Phone03-6214-3600
Websitewww.gnipharma.com
Company Executives
- Name
- Position
- Salary
- Dr. Ying Luo, PhD
- Director, Representative Executive Officer, President and Chief Executive Officer
- --
- Toshiya Kitagawa
- Director, Executive Officer and Chief Financial Officer
- --
- Sekitani Kazuki
- Director, Executive Officer and Chief Operating Officer
- --
- Thomas Eastling
- Director
- --
- Ryosuke Matsui
- Director
- --
- Hideaki Sashiwa
- Independent Director
- --
- Kikuchi Kanako
- Independent Director
- --
- Zhang Ping
- Independent Director
- --